Thomas Relander
Impact in
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment
- Hematology top 10%
- Hematopoietic Stem Cell Transplantation
Papers in
-
- Lymphoma Diagnosis and Treatment 43
-
- Childhood Cancer Survivors' Quality of Life 6
- Co-authors
- Mats Jerkeman (17 shared papers)Fredrik Ellin (14 shared papers)Hans Hagberg (12 shared papers)Eva K. Cavallin-Ståhl (9 shared papers)Francesco d’Amore (18 shared papers)Joseph M. Connors (6 shared papers)Martin Erlanson (9 shared papers)Peter de Nully Brown (9 shared papers)
In The Last Decade
Thomas Relander
62 papers receiving 2.3k citations
Thomas Relander's Hit Papers
Peers
Comparison fields: 5 of 54
- Pathology and Forensic Medicine 1.6k
- Hematology 128
- Pediatrics, Perinatology and Child Health 123
- Reproductive Medicine 83
- Oncology 151
Countries citing papers authored by Thomas Relander
This map shows the geographic impact of Thomas Relander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Relander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Relander more than expected).
Fields of papers citing papers by Thomas Relander
This network shows the impact of papers produced by Thomas Relander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Relander. The network helps show where Thomas Relander may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Relander, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01 Hit paper breakdown → | 2012 | 473 |
| 2 | Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry Hit paper breakdown → | 2014 | 321 |
| 3 | 2010 | 153 | |
| 4 | 2010 | 124 | |
| 5 | 2008 | 106 | |
| 6 | 2000 | 88 | |
| 7 | 2009 | 75 | |
| 8 | 2020 | 70 | |
| 9 | 2010 | 68 | |
| 10 | 2010 | 67 | |
| 11 | 2017 | 65 | |
| 12 | 2017 | 58 | |
| 13 | 2009 | 57 | |
| 14 | 2015 | 42 | |
| 15 | 2004 | 39 | |
| 16 | 2008 | 38 | |
| 17 | 2005 | 33 | |
| 18 | 2017 | 33 | |
| 19 | 2010 | 30 | |
| 20 | 2021 | 28 |
About Thomas Relander
Thomas Relander is a scholar working on Pathology and Forensic Medicine, Pediatrics, Perinatology and Child Health, Genetics, Neurology and Public Health, Environmental and Occupational Health, having authored 66 papers that have together received 2.4k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (43 papers), Virus-based gene therapy research (7 papers), Childhood Cancer Survivors' Quality of Life (6 papers), Reproductive Biology and Fertility (5 papers), CNS Lymphoma Diagnosis and Treatment (4 papers), Viral-associated cancers and disorders (2 papers), Acute Lymphoblastic Leukemia research (2 papers) and Hypothalamic control of reproductive hormones (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (1.6k citations), Hematology (128 citations), Pediatrics, Perinatology and Child Health (123 citations), Reproductive Medicine (83 citations) and Oncology (151 citations). Thomas Relander has collaborated with scholars based in Sweden, Denmark and Norway. Frequent co-authors include Mats Jerkeman, Fredrik Ellin, Hans Hagberg, Eva K. Cavallin-Ståhl, Francesco d’Amore, Joseph M. Connors, Martin Erlanson, Peter de Nully Brown, Nathalie A. Johnson and Randy D. Gascoyne. Their work appears in journals such as Blood, British Journal of Haematology, Journal of Clinical Oncology, Blood Advances and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.